CIAM
IMVT icon

Caitong International Asset Management’s Immunovant IMVT Stock Holding History

Caitong International Asset Management’s Portfolio IMVT Stock Details IMVT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$22.8K Sell
591
-1,292
-69% -$39.4K ﹤0.01% 948
2026
Q1 		$46.8K Buy
+1,883
New +$48.8K 0.01% 807
2025
Q3 		– Sell
-5
Closed -$80 – 2216
2025
Q2 		$80 Sell
5
-3,974
-100% -$60.1K ﹤0.01% 1851
2025
Q1 		$68K Buy
3,979
+2,863
+257% +$59.9K 0.05% 395
2024
Q4 		$27.6K Buy
+1,116
New +$31.7K 0.03% 687

Other funds holding IMVT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Caitong International Asset Management's IMVT Position: Q2 2026 in Review

Caitong International Asset Management reduced its Immunovant (IMVT) stake by 69% in Q2 2026, selling an estimated $39.4K and leaving 591 shares worth $22.8K. The position accounts for ﹤0.01% of the portfolio, ranked #948.

Caitong International Asset Management first reported a position in IMVT in Q4 2024 and has held it in 5 quarters since. The position peaked at $68K in Q1 2025. 226 funds tracked by Wall St. Rank hold IMVT as of Q2 2026.

  • Caitong International Asset Management held 591 shares of Immunovant worth $22.8K as of Q2 2026.
  • Caitong International Asset Management sold 1,292 Immunovant shares in Q2 2026, an estimated $39.4K.
  • Immunovant made up ﹤0.01% of Caitong International Asset Management's portfolio in Q2 2026, its #948 holding.
  • Caitong International Asset Management first reported a position in Immunovant in Q4 2024 and has held it in 5 quarters since.
  • Caitong International Asset Management's Immunovant position peaked at $68K in Q1 2025.
  • 226 funds tracked by Wall St. Rank held Immunovant as of Q2 2026.

Based on Caitong International Asset Management's 13F filing for Q2 2026, filed 5 Aug 2026.